2-214792458-TAAAA-TA

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP6_Very_StrongBS1BS2_Supporting

The NM_000465.4(BARD1):​c.216-16_216-14del variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00175 in 1,396,112 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.000071 ( 0 hom., cov: 0)
Exomes 𝑓: 0.0019 ( 1 hom. )

Consequence

BARD1
NM_000465.4 splice_polypyrimidine_tract, intron

Scores

Not classified

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.804
Variant links:
Genes affected
BARD1 (HGNC:952): (BRCA1 associated RING domain 1) This gene encodes a protein which interacts with the N-terminal region of BRCA1. In addition to its ability to bind BRCA1 in vivo and in vitro, it shares homology with the 2 most conserved regions of BRCA1: the N-terminal RING motif and the C-terminal BRCT domain. The RING motif is a cysteine-rich sequence found in a variety of proteins that regulate cell growth, including the products of tumor suppressor genes and dominant protooncogenes. This protein also contains 3 tandem ankyrin repeats. The BARD1/BRCA1 interaction is disrupted by tumorigenic amino acid substitutions in BRCA1, implying that the formation of a stable complex between these proteins may be an essential aspect of BRCA1 tumor suppression. This protein may be the target of oncogenic mutations in breast or ovarian cancer. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP6
Variant 2-214792458-TAAA-T is Benign according to our data. Variant chr2-214792458-TAAA-T is described in ClinVar as [Likely_benign]. Clinvar id is 490957.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. gnomad4_exome allele frequency = 0.00191 (2428/1268842) while in subpopulation AMR AF= 0.00678 (163/24058). AF 95% confidence interval is 0.00593. There are 1 homozygotes in gnomad4_exome. There are 1219 alleles in male gnomad4_exome subpopulation. This position pass quality control queck.
BS2
High AC in GnomAd4 at 9 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
BARD1NM_000465.4 linkuse as main transcriptc.216-16_216-14del splice_polypyrimidine_tract_variant, intron_variant ENST00000260947.9 NP_000456.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
BARD1ENST00000260947.9 linkuse as main transcriptc.216-16_216-14del splice_polypyrimidine_tract_variant, intron_variant 1 NM_000465.4 ENSP00000260947 P2Q99728-1

Frequencies

GnomAD3 genomes
AF:
0.0000707
AC:
9
AN:
127240
Hom.:
0
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.0000291
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000230
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000305
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000338
Gnomad OTH
AF:
0.000574
GnomAD3 exomes
AF:
0.00582
AC:
561
AN:
96390
Hom.:
1
AF XY:
0.00612
AC XY:
322
AN XY:
52578
show subpopulations
Gnomad AFR exome
AF:
0.00509
Gnomad AMR exome
AF:
0.00895
Gnomad ASJ exome
AF:
0.00397
Gnomad EAS exome
AF:
0.000601
Gnomad SAS exome
AF:
0.00606
Gnomad FIN exome
AF:
0.00628
Gnomad NFE exome
AF:
0.00594
Gnomad OTH exome
AF:
0.00551
GnomAD4 exome
AF:
0.00191
AC:
2428
AN:
1268842
Hom.:
1
AF XY:
0.00194
AC XY:
1219
AN XY:
628372
show subpopulations
Gnomad4 AFR exome
AF:
0.00198
Gnomad4 AMR exome
AF:
0.00678
Gnomad4 ASJ exome
AF:
0.00231
Gnomad4 EAS exome
AF:
0.000300
Gnomad4 SAS exome
AF:
0.00268
Gnomad4 FIN exome
AF:
0.00240
Gnomad4 NFE exome
AF:
0.00175
Gnomad4 OTH exome
AF:
0.00214
GnomAD4 genome
AF:
0.0000707
AC:
9
AN:
127270
Hom.:
0
Cov.:
0
AF XY:
0.0000491
AC XY:
3
AN XY:
61158
show subpopulations
Gnomad4 AFR
AF:
0.0000290
Gnomad4 AMR
AF:
0.000230
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000305
Gnomad4 NFE
AF:
0.0000339
Gnomad4 OTH
AF:
0.000570

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Likely benign, criteria provided, single submitterclinical testingCenter for Genomic Medicine, Rigshospitalet, Copenhagen University HospitalAug 15, 2023- -
Hereditary cancer-predisposing syndrome Benign:1
Likely benign, criteria provided, single submitterclinical testingColor Diagnostics, LLC DBA Color HealthJun 24, 2017- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs56130510; hg19: chr2-215657182; API